Stay in the know
Receive timely insights and briefings from HSF Kramer, tailored to keep you informed and ahead
Subscribe now
Herbert Smith Freehills Kramer (HSF Kramer) is pleased to be advising CSL on its recently announced proposed demerger of its Seqirus business (Seqirus) as a standalone ASX-listed entity by the end of Financial Year 2026.
Seqirus is one of the world’s largest influenza vaccine providers, dedicated to advancing public health through innovative vaccine solutions and pandemic preparedness.
The HSF Kramer team is led by partners Priscilla Bryans, Baden Furphy, Alexander Mackinnon, and Michael Ziegelaar, with partner Ryan Leslie advising on the tax aspects of the transaction.
Key contacts
Priscilla Bryans
Partner, Melbourne
Baden Furphy
Partner, Melbourne
Alexander Mackinnon
Partner, Melbourne
Michael Ziegelaar
Partner, Melbourne
Ryan Leslie
Partner, Melbourne
Media contact
For further information on this news article, please contact:
Gina Baldassarre
External Communications Manager
Sydney
More news
10 8월 2026
Herbert Smith Freehills Kramer advises Indosat on 1GW Southeast Asia AI infrastructure platform
Herbert Smith Freehills Kramer has advised Indosat Ooredoo Hutchison on the establishment of its partnership with Ooredoo Group, Nokia and NVIDIA to …
10 8월 2026
Jay A Neveloff and Jonathan H Canter named to Lawdragon 500's 2026 Leading Real Estate Lawyers list
The 2026 Lawdragon 500 Leading Real Estate Lawyers guide has named Jay Neveloff and Jonathan H. Canter for the third consecutive year, in recognition of …
6 8월 2026
Herbert Smith Freehills Kramer advises Jefferies and J.P. Morgan on Tritax Big Box REIT's £350 million equity raise for data centre development
Leading global law firm Herbert Smith Freehills Kramer has advised Jefferies International Limited and J.P. Morgan Securities plc, which conducts its UK …